Location History:
- Duxford Cambridge, GB (1999)
- Duxford, GB (2006)
- Cambridge, GB (1995 - 2014)
Company Filing History:
20 out of 156 
14 out of 338 
3 out of 76 
Years Active: 1995-2014
Areas of Expertise:
Title: David John Grainger: Innovator and Patent Holder
Introduction:
David John Grainger, a prolific inventor and innovator based in Cambridge, GB, has made significant contributions to the field of pharmaceutical research and development. With an impressive number of 41 patents under his name, Grainger has played a vital role in advancing the treatment of inflammatory disorders and the modulation of G-protein coupled receptors (GPCRs). In this article, we will explore Grainger's latest patents, career highlights, collaborations, and his lasting impact on the field of pharmaceuticals.
Latest Patents:
Among Grainger's recent patents, two notable inventions stand out. The first is the development of a treatment for rheumatoid arthritis using 3-amino lactam compounds. This patent focuses on the compound 3-(2',2'-dimethylpropanoylamino)-tetrahydropyridin-2-one, its pharmaceutical compositions, and its efficacy in preventing or treating inflammatory disorders.
The second patent involves the creation of ligand libraries for screening GPCRs. Grainger devised compounds (I)-(IV) or their pharmaceutically acceptable salts for medicinal use. These compounds pave the way for the development of new medicaments aimed at modulating the activity of GPCRs. Additionally, they offer the potential to construct compound libraries that enable efficient screening for agents influencing GPCR signaling.
Career Highlights:
Throughout his career, Grainger has worked with esteemed organizations, including Neorx Corporation and Cambridge Enterprise Limited. Collaborating with innovative minds, he has made valuable contributions to the research and development of cutting-edge pharmaceutical solutions. Grainger's dedication and expertise have garnered him unique insights into the field, leading to the creation of numerous patents and groundbreaking inventions.
Collaborations:
Within the realm of pharmaceutical research, collaborations with talented individuals are crucial to push the boundaries of innovation. Grainger has had the opportunity to work alongside notable colleagues such as James C Metcalfe and Peter L Weissberg. These collaborations have facilitated the exchange of ideas, expertise, and resources, fostering a dynamic environment for innovation and invention.
Conclusion:
David John Grainger has established himself as a distinguished inventor in the field of pharmaceuticals, leaving a remarkable impact on the treatment of inflammatory disorders and the modulation of GPCRs. With an impressive portfolio of 41 patents, his contributions have played a significant role in advancing medical research and development. Grainger's successful career and collaborative efforts highlight the importance of interdisciplinary cooperation in driving innovation and improving healthcare outcomes.